Monopar Therapeutics Inc. (MNPR) Statistics & Valuation Metrics - Stocknear

Monopar Therapeutics Inc.

NASDAQ: MNPR · Real-Time Price · USD
76.63
-0.81 (-1.05%)
At close: Sep 26, 2025, 3:59 PM
75.10
-2.00%
After-hours: Sep 26, 2025, 05:41 PM EDT

Monopar Therapeutics Statistics

Share Statistics

Monopar Therapeutics has 6.17M shares outstanding. The number of shares has increased by 73.71% in one year.

6.17M
73.71%
0.21%
4.13%
3.95M
193
0.37%

Short Selling Information

The latest short interest is 146.9K, so 2.38% of the outstanding shares have been sold short.

146.9K
2.38%
7.38%
3.92

Valuation Ratios

The PE ratio is -5.35 and the forward PE ratio is -21.27. Monopar Therapeutics's PEG ratio is -0.01.

-5.35
-21.27
0
746.5
1.51
-13.02
-0.01
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Monopar Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 11.47, with a Debt / Equity ratio of 0.

11.47
11.47
0
n/a
n/a
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.11M
14
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 1031.91% in the last 52 weeks. The beta is 1.22, so Monopar Therapeutics's price volatility has been higher than the market average.

1.22
1031.91%
44.71
37.57
80.04
51,753

Income Statement

n/a
n/a
-16.16M
-15.59M
-15.59M
-15.59M
-4.11
Full Income Statement

Balance Sheet

The company has 45.82M in cash and 0 in debt, giving a net cash position of 45.82M.

45.82M
n/a
n/a
-75.79B
53.87B
52.16B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.4M and capital expenditures 0, giving a free cash flow of -6.4M.

-6.4M
n/a
-6.4M
-1.69
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

MNPR does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for MNPR is $80, which is 4.4% higher than the current price. The consensus rating is "Buy".

$80
4.4%
Buy
10
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Aug 13, 2024. It was a backward split with a ratio of 1:5.

Aug 13, 2024
backward
1:5

Scores

-0.8
1